Literature DB >> 2426696

ras p21 deletion mutants and monoclonal antibodies as tools for localization of regions relevant to p21 function.

J C Lacal, S A Aaronson.   

Abstract

Deletion mutants of the viral Harvey ras oncogene were generated by removing different lengths of the gene from either the amino or the carboxyl terminus. The deletion mutants, ras p21 expressed in Escherichia coli, yielded proteins of approximately 8, 10, 12, 14, 17, 18, 19, and 20 kDa. These proteins were utilized to identify epitopes recognized by a series of recently generated monoclonal antibodies as well as some previously reported monoclonal antibodies. Monoclonal antibodies that inhibited GTP binding, a major biochemical activity of the p21 protein, recognized two major regions of the protein. These regions were localized from amino acids 5 to 69 and 107 to 164, respectively, and were separated by another stretch from residues 70 to 106, whose antigenic determinants were not directly involved in GTP binding. Thus, the mapping of epitopes within the p21 molecule recognized by monoclonal antibodies has made it possible to localize important functional regions within the ras p21 molecule.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426696      PMCID: PMC386294          DOI: 10.1073/pnas.83.15.5400

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses.

Authors:  R C Nowinski; M E Lostrom; M R Tam; M R Stone; W N Burnette
Journal:  Virology       Date:  1979-02       Impact factor: 3.616

2.  Monoclonal antibody Y13-259 recognizes an epitope of the p21 ras molecule not directly involved in the GTP-binding activity of the protein.

Authors:  J C Lacal; S A Aaronson
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

3.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

4.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

5.  Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

Authors:  Y Yuasa; S K Srivastava; C Y Dunn; J S Rhim; E P Reddy; S A Aaronson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

6.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

7.  Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses.

Authors:  E M Scolnick; A G Papageorge; T Y Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.

Authors:  T Y Shih; A G Papageorge; P E Stokes; M O Weeks; E M Scolnick
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

9.  Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses.

Authors:  T Y Shih; P E Stokes; G W Smythers; R Dhar; S Oroszlan
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

10.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

View more
  11 in total

1.  cDNA sequence of a new ras-related gene (rap2b) isolated from human platelets with sequence homology to rap2.

Authors:  F X Farrell; C A Ohmstede; B R Reep; E G Lapetina
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

2.  RAP2B: a RAS-related GTP-binding protein from platelets.

Authors:  C A Ohmstede; F X Farrell; B R Reep; K J Clemetson; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Microinjection of Rap2B protein or RNA induces rearrangement of pigment granules in Xenopus oocytes.

Authors:  M J Campa; F X Farrell; E G Lapetina; K J Chang
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

4.  A ras-related protein is phosphorylated and translocated by agonists that increase cAMP levels in human platelets.

Authors:  E G Lapetina; J C Lacal; B R Reep; L Molina y Vedia
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Activation of ras p21 transforming properties associated with an increase in the release rate of bound guanine nucleotide.

Authors:  J C Lacal; S A Aaronson
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  Thrombolamban, the 22-kDa platelet substrate of cyclic AMP-dependent protein kinase, is immunologically homologous with the Ras family of GTP-binding proteins.

Authors:  T E White; J C Lacal; B Reep; T H Fischer; E G Lapetina; G C White
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

7.  Association of the low molecular weight GTP-binding protein rap2B with the cytoskeleton during platelet aggregation.

Authors:  M Torti; G Ramaschi; F Sinigaglia; E G Lapetina; C Balduini
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

8.  Association of p21ras with phosphatidylinositol 3-kinase.

Authors:  A Sjölander; K Yamamoto; B E Huber; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

9.  Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells.

Authors:  G H Cohen; W C Wilcox; D L Sodora; D Long; J Z Levin; R J Eisenberg
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein.

Authors:  C T Siegel; K Schreiber; S C Meredith; G B Beck-Engeser; D W Lancki; C A Lazarski; Y X Fu; D A Rowley; H Schreiber
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.